Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA).
about
Validation of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).Frequency and Prognostic Impact of Consistently Low Edmonton Symptom Assessment System Score in the Patients Treated with Palliative Radiotherapy.Stereotactic Radiosurgery in the Management of Patients With Brain Metastases of Non-Small Cell Lung Cancer: Indications, Decision Tools and Future Directions.
P2860
Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA).
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Validation of the graded progn ...... lecular markers (lung-molGPA).
@ast
Validation of the graded progn ...... lecular markers (lung-molGPA).
@en
type
label
Validation of the graded progn ...... lecular markers (lung-molGPA).
@ast
Validation of the graded progn ...... lecular markers (lung-molGPA).
@en
prefLabel
Validation of the graded progn ...... lecular markers (lung-molGPA).
@ast
Validation of the graded progn ...... lecular markers (lung-molGPA).
@en
P2093
P2860
P1433
P1476
Validation of the graded progn ...... lecular markers (lung-molGPA).
@en
P2093
Anca L Grosu
Angelika Bilger
Carsten Nieder
Mandy Hintz
Oliver Oehlke
P2860
P2888
P356
10.1186/S13014-017-0844-6
P577
2017-06-26T00:00:00Z
P6179
1086319415